Sigma Diagnostics Signs New Distribution Agreement for Coagulation Systems
Under the agreement, Allegiance will have the right to distribute all of Sigma Diagnostics' coagulation products. This includes the automated AMAX series (AMAX 190, AMAX 190m, AMAX 400) and manual systems (KC1, KC 4), including the recently released Sigma-Amelung AMAX 200 and AUTO D-Dimer kit. Sigma markets a full line of coagulation reagents optimized to the Sigma-Amelung Systems. This agreement will enhance Sigma Diagnostics' ability to meet the needs of coagulation customers.
"We are totally dedicated to the coagulation market and this agreement goes a long way to enhance our commitment. Allegiance brings to the marketplace the same quality and service focus as Sigma Diagnostics," said Bob Monaghan, President of Sigma Diagnostics.
Through its subsidiaries, Allegiance Healthcare Corporation is a leading provider of health-care products and cost-management services needed by hospitals, laboratories and others in health care. Based in McGaw Park, Illinois, the company manufactures many of the products it markets and distributes, while others come from health and medical companies around the world. Allegiance also provides integrated services such as clinical and productivity consulting, procedure-based supply packaging, just-in-time delivery and other services to help medical professionals control costs and improve quality in patient care. Allegiance is a subsidiary of Cardinal Health, Inc.,(NYSE:CAH), a leading provider of products and services supporting the health-care industry. Allegiance conducts e-business through www.cardinal.com. More information about Allegiance can be found at that site, or by visiting www.allegiance.net.
Most read news
Organizations
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.